Tealwood Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-17,324
Closed -$991K – 124
2026
Q2
$991K Sell
17,324
-678
-4% -$37.1K 0.38% 112
2026
Q1
$1.02M Sell
18,002
-157
-0.9% -$9.15K 0.46% 105
2025
Q4
$1.08M Sell
18,159
-2,582
-12% -$141K 0.48% 101
2025
Q3
$1.12M Sell
20,741
-822
-4% -$47K 0.45% 105
2025
Q2
$1.19M Buy
21,563
+5,874
+37% +$346K 0.53% 102
2025
Q1
$1.11M Buy
15,689
+156
+1% +$10.5K 0.51% 99
2024
Q4
$1.02M Sell
15,533
-117
-0.7% -$7.84K 0.42% 111
2024
Q3
$1.1M Buy
15,650
+3,503
+29% +$293K 0.48% 111
2024
Q2
$1M Sell
12,147
-54
-0.4% -$4.5K 0.6% 84
2024
Q1
$1.07M Sell
12,201
-225
-2% -$20.1K 0.48% 108
2023
Q4
$1.2M Sell
12,426
-323
-3% -$28.6K 0.57% 91
2023
Q3
$1.13M Sell
12,749
-274
-2% -$24.4K 0.58% 89
2023
Q2
$1.13M Sell
13,023
-233
-2% -$21.9K 0.55% 98
2023
Q1
$1.29M Sell
13,256
-157
-1% -$16.3K 0.66% 70
2022
Q4
$1.39M Sell
13,413
-1,146
-8% -$108K 0.73% 59
2022
Q3
$1.23M Sell
14,559
-43
-0.3% -$3.83K 0.67% 64
2022
Q2
$1.21M Sell
14,602
-368
-2% -$29.3K 0.6% 76
2022
Q1
$1.15M Sell
14,970
-244
-2% -$20.4K 0.49% 106
2021
Q4
$1.34M Buy
+15,214
New +$1.26M 0.54% 92

Other funds holding BMRN

Tealwood Asset Management's BMRN Position: Q3 2026 in Review

Tealwood Asset Management sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2026, closing a stake of 17,324 shares — an estimated $991K sold.

Tealwood Asset Management first reported a position in BMRN in Q4 2021 and held it in 19 quarters. The position peaked at $1.39M in Q4 2022. 25 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.

  • Tealwood Asset Management reported no remaining BioMarin Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Tealwood Asset Management sold 17,324 BioMarin Pharmaceuticals shares in Q3 2026, an estimated $991K.
  • Tealwood Asset Management first reported a position in BioMarin Pharmaceuticals in Q4 2021 and held it in 19 quarters.
  • Tealwood Asset Management's BioMarin Pharmaceuticals position peaked at $1.39M in Q4 2022.
  • 25 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.

Based on Tealwood Asset Management's 13F filing for Q3 2026, filed 13 Oct 2026.